Clinical Trial Update: Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2/3 study evaluating the clinical efficacy of ABX203 Therapeutic Vaccine in HBeAg-negative chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ABX203 Therapeutic Vaccine

Snippet

Sponsor: Abivax S.A. | Conditions: Chronic Hepatitis B | Phase 2, Phase 3 | Status: COMPLETED